Arax Advisory Partners’s AYTU BioPharma AYTU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4 Hold
2
– – ﹤0.01% 5367
2026
Q2
$4 Buy
+2
New +$5 ﹤0.01% 5197
2021
Q4
– Hold
0
– – – 1140
2021
Q3
– Hold
0
– – – 993
2021
Q2
– Hold
0
– – – 916

Other funds holding AYTU

Arax Advisory Partners's AYTU Position: Q3 2026 in Review

Arax Advisory Partners held its AYTU BioPharma (AYTU) position steady in Q3 2026 at 2 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #5367.

Arax Advisory Partners first reported a position in AYTU in Q2 2026 and has held it in 2 quarters since. 36 funds tracked by Wall St. Rank hold AYTU as of Q3 2026.

  • Arax Advisory Partners held 2 shares of AYTU BioPharma worth $4 as of Q3 2026.
  • Arax Advisory Partners left its AYTU BioPharma share count unchanged in Q3 2026.
  • AYTU BioPharma made up ﹤0.01% of Arax Advisory Partners's portfolio in Q3 2026, its #5367 holding.
  • Arax Advisory Partners first reported a position in AYTU BioPharma in Q2 2026 and has held it in 2 quarters since.
  • 36 funds tracked by Wall St. Rank held AYTU BioPharma as of Q3 2026.

Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.